U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588425) titled 'Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer' on May 03.
Brief Summary: The goal of this observational study is to evaluate cardiac side effects in women with early-stage breast cancer who receive systemic chemotherapy and/or anti-HER2 therapy as part of their standard cancer care.
The main questions it aims to answer are:
Can changes in Global Longitudinal Strain (GLS) on echocardiography detect early cardiac dysfunction before a drop in left ventricular ejection fraction (LVEF) becomes apparent? Are changes in circulating microRNA levels in the blood associated with early cardiac dysfunction during cancer...